Pursuant to the RTO, Silo Wellness indirectly acquired, through an amalgamation with its wholly owned subsidiary, all of the issued and outstanding securities of Yukoterre, a publicly traded company listed on the CSE, in exchange for common shares of Silo Wellness.

Silo Wellness’ activities have focused on the development of psilocybin-free functional mushroom tinctures, the development of the formulation of a psilocybin nasal spray in Jamaica and offering Jamaican and Oregon psychedelic wellness retreats and the Jamaican cultivation of psychedelic mushrooms.